Project Mercury publishes its Interim Progress Report 2023–2025 — a document that captures two years of coordinated, patient-led effort to prepare the world for FSHD
From 1–3 May 2026, representatives from Project Mercury participated in the 295th ENMC International Workshop on “Harmonizing Clinical Monitoring in FSHD”, held in Hoofddorp, The
In April, the Project Mercury Global Task Force (GTF) convened virtually for its quarterly meeting, bringing together patient advocacy leaders, clinicians, researchers, and partners from
Early April, Project Mercury was proud to be represented at the SOLVE FSHD meeting in Canada, where our Chair, Emma Weatherley, shared our work with
Today, March 19th, 2026, FSHD Europe announced its collaboration with TREAT-NMD and the PaLaDIn consortium to develop an FSHD disease model for health technology assessment
We celebrate a powerful step forward in raising awareness for Facioscapulohumeral Muscular Dystrophy (FSHD). Under the motto “1 in 10,000”, the FSHD Spain has launched
Facioscapulohumeral muscular dystrophy (FSHD) is at a turning point, with multiple disease-modifying therapies in development. To ensure global access, clinical trial readiness across diverse regions